Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as diagnostic markers for pneumonia severity

British Journal of Biomedical Science

Volumn 73, Issue 3, 2016, Pages 140-142

  Lee, Jong Han ^a   Song, Sungwook ^b   Yoon, Soo Young ^c   Lim, Chae Seung ^c   Song, Jae Woo ^d   Kim, Hyon Suk ^d  

^a Osan Hankook Hospital   (South Korea)

^b Korean Red Cross   (South Korea)

^c Korea University College of Medicine   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

c reactive protein; Neutrophil to lymphocyte ratio; platelet to lymphocyte ratio; pneumonia severity

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; PROCALCITONIN;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; EVIDENCE BASED PRACTICE; FEMALE; HALF LIFE TIME; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; NEUTROPHIL LYMPHOCYTE RATIO; PLASMA HALF LIFE; PLATELET LYMPHOCYTE RATIO; PNEUMONIA; PNEUMONIA SEVERITY INDEX; PRIORITY JOURNAL; RISK FACTOR; TREATMENT RESPONSE; BLOOD; IMMUNOLOGY; LYMPHOCYTE COUNT; MIDDLE AGED; NEUTROPHIL; SEVERITY OF ILLNESS INDEX; THROMBOCYTE COUNT; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHILS; PLATELET COUNT; PNEUMONIA; SEVERITY OF ILLNESS INDEX;

EID: 84990946909     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2016.1209898     Document Type: Article

References (18)

1. S.Kandi. Diagnosis of community acquired pneumonia. J. Assoc. Physicians India. 2012;60:17–20.
2. W.S.Lim, M.M.van der Eerden, R.Laing,. Defining community acquired pneumonia severity on presentation to hospital:an international derivation and validation study. Thorax. 2003;58:377–382.10.1136/thorax.58.5.377
3. M.Di Napoli, M.S.Elkind, D.A.Godoy,. Role of C-reactive protein in cerebrovascular disease:a critical review. Expert Rev. Cardiovasc. Ther. 2011;9:1565–1584.10.1586/erc.11.159
4. J.D.Chalmers, A.Singanayagam, A.T.Hill. C-reactive protein is an independent predictor of severity in communityacquired pneumonia. Am. J. Med. 2008;121:219–225.10.1016/j.amjmed.2007.10.033
5. R.P.Smith, B.J.Lipworth. C-reactive protein in simple community-acquired pneumonia. Chest. 1995;107:1028–1031.10.1378/chest.107.4.1028
6. E.N.Rifaioglu, B.Bulbul Sen, O.Ekiz,. Neutrophil to lymphocyte ratio in Behcet’s disease as a marker of disease activity. Acta Dermatovenerol. Alp. Pannonica Adriat. 2014;23:65–67.
7. N.B.Yoon, C.Son, S.J.Um. Role of the neutrophil–lymphocyte count ratio in the differential diagnosis between pulmonary tuberculosis and bacterial community-acquired pneumonia. Ann. Lab. Med. 2013;33:105–110.10.3343/alm.2013.33.2.105
8. S.Balta, C.Ozturk. The platelet-lymphocyte ratio:a simple, inexpensive and rapid prognostic marker for cardiovascular events. Platelets. 2015;26:680–681.10.3109/09537104.2014.979340
9. H.Kim, Y.Kim, K.H.Kim,. Use of delta neutrophil index for differentiating low-grade community-acquired pneumonia from upper respiratory infection. Ann. Lab. Med. 2015;35:647–650.10.3343/alm.2015.35.6.647
10. M.B.Pepys, G.M.Hirschfield. C-reactive protein:a critical update. J. Clin. Invest. 2003;111:1805–1812.10.1172/JCI200318921
11. C.Haslett. Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am. J. Respir. Crit. Care Med. 1999;160:S5–S11.10.1164/ajrccm.160.supplement_1.4
12. A.J.Young, J.B.Hay. Rapid turnover of the recirculating lymphocyte pool in vivo. Int. Immunol. 1995;7:1607–1615.10.1093/intimm/7.10.1607
13. L.A.Harker, L.K.Roskos, U.M.Marzec,. Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers. Blood. 2000;95:2514–2522.
14. F.Imtiaz, K.Shafique, S.S.Mirza,. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int. Arch. Med. 2012;5:2.10.1186/1755-7682-5-2
15. C.P.de Jager, P.C.Wever, E.F.Gemen,. The neutrophil–lymphocyte count ratio in patients with communityacquired pneumonia. PLOS ONE. 2012;7:e46561.10.1371/journal.pone.0046561
16. J.H.Lee, S.Y.Yoon, H.S.Kim,. Characteristics of the mean platelet volume, neutrophil to lymphocyte ratio, and C-reactive protein compared to the procalcitonin level in pneumonia patients. Platelets. 2015;26:278–280.10.3109/09537104.2013.875138
17. K.M.Sarraf, E.Belcher, E.Raevsky,. Neutrophil/ lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 2009;137:425–428.10.1016/j.jtcvs.2008.05.046
18. S.R.Walsh, E.J.Cook, F.Goulder,. Neutrophil– lymphocyte ratio as a prognostic factor in colorectal cancer. J. Surg. Oncol. 2005;91:181–184.10.1002/(ISSN)1096-9098